There isn't a COVID-19 vaccination or particular antiviral drug available yet. In order to preserve lives and stop the disease's spread, a readily available, efficient, and secure therapy is desperately needed. Acute respiratory distress syndrome plays a major role in COVID-19 death rates. The characteristic of acute respiratory distress syndrome is markedly elevated oxidative stress brought on by a fast release of free radicals and cytokines (cytokine storm), which can result in organ failure, cellular damage, and even death. We describe a case where the patient responded well to early administration of high dose intravenous vitamin C in addition to other nutrients and drugs.
No takes yet. Share an insight, caveat, or question.
Nsaku Nswadi (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: